Search | IOVS | ARVO Journals

View

Showing 1 – 18 of 18

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract September 2016

Early Micro-incisional Pars Plana Vitrectomy for the treatment of Acute Infective Endophthalmitis: The Sydney Eye Hospital Experience

Guillermo Fernandez-Sanz; Steve Levasseur; Eugene Ting; Gerald Liew; Justin Playfair; John Downie; Mark Gorbatov; Alex Paul Hunyor; Andrew Alexander Chang; I-Van Ho

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):4459. doi:

ARVO Annual Meeting Abstract September 2016

Intravitreal Aflibercept for Treatment-Resistant Neovascular Age-related Macular Degeneration Patients: 3-Year Outcomes

Wijeyanthy Wijeyakumar; Meidong Zhu; Andrew Alexander Chang

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):4965. doi:

ARVO Annual Meeting Abstract September 2016

Quality of corneas from the donors with neovascular age-related macular degeneration

Meidong Zhu; Wijeyanthy Wijeyakumar; Bobak Bahrami; Jane Treloggen; Andrew Alexander Chang

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):6211. doi:

ARVO Annual Meeting Abstract September 2016

The clinical utility of microperimetry in eyes undergoing vitrectomy surgery for epiretinal membrane.

Shaun YP Ewe; Bobak Bahrami; Adil Syed; Thomas Hai Le Hong; Meidong Zhu; Andrew Alexander Chang

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):1096. doi:

ARVO Annual Meeting Abstract September 2016

The efficacy of aflibercept in the management of treatment-resistant diabetic macular edema: a 12-month prospective study

Bobak Bahrami; Shaun Ewe; Thomas Hai Le Hong; Meidong Zhu; Andrew Alexander Chang

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):2070. doi:

ARVO Annual Meeting Abstract June 2015

Intravitreal Aflibercept for Treatment-Resistant Diabetic Macular Edema: 3-month findings

Andrew Alexander Chang; Thomas Hai Le Hong; Geoffrey Broadhead; Lily Wong; Nichole Joachim; Adil Syed; Meidong Zhu

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):1761. doi:

ARVO Annual Meeting Abstract June 2015

Fate of non-perfused vessels in ischemic retina

Marcus Fruttiger; Michael Powner; Ryan Jones; Weijen Tan; Meidong Zhu; Andrew Alexander Chang; Dawn A Sim; Pearse Andrew Keane; Adnan Tufail; Catherine A Egan

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):3332. doi:

ARVO Annual Meeting Abstract June 2015

Intravitreal Aflibercept for Treatment-Resistant Neovascular Age-Related Macular Degeneration: 2-year Outcomes

Thomas Hai Le Hong; Geoffrey Broadhead; Nichole Joachim; Lily Wong; Meidong Zhu; Andrew Alexander Chang

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):4593. doi:

ARVO Annual Meeting Abstract June 2015

Morphological changes with Intravitreal Aflibercept for Treatment Resistant Neovascular Age-Related Macular Degeneration

Lily Wong; Thomas Hai Le Hong; Geoffrey Broadhead; Meidong Zhu; Andrew Alexander Chang

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):4619. doi:

ARVO Annual Meeting Abstract June 2015

Comparison of aflibercept treatment regimes for treatment-resistant neovascular age-related macular degeneration: 8 weekly versus an ‘as-needed’ regime

Wijeyanthy Wijeyakumar; Meidong Zhu; Geoffrey Broadhead; Thomas Hai Le Hong; Andrew Alexander Chang

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):4620. doi:

ARVO Annual Meeting Abstract June 2015

Correlation of pre-mortem and post-mortem spectral domain optical coherence tomography (SD-OCT) in examination of normal and diseased human retinas

Meidong Zhu; Adil Syed; Andrew Alexander Chang

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):5946. doi:

ARVO Annual Meeting Abstract June 2015

Morphological and Functional Predictors of Imminent Neovascularisation in Age-Related Macular Degeneration

Geoffrey Broadhead; John R Grigg; Peter McCluskey; Thomas Hai Le Hong; Adil Syed; Andrew Alexander Chang

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):5355. doi:

ARVO Annual Meeting Abstract April 2014

Retinal Morphology Changes Following Intravitreal Aflibercept for Treatment-Resistant Neovascular Age-Related Macular Degeneration

Geoffrey Broadhead; Thomas Hong; Haitao Li; Meidong Zhu; Wijeyanthy Wijeyakumar; Andrew Alexander Chang; Sydney Institute of Vision Science

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):3924. doi:

ARVO Annual Meeting Abstract April 2014

Response of Pigment Epithelial Detachments following Intravitreal Aflibercept for Age-Related Macular Degeneration

Thomas Hong; Geoffrey Broadhead; Meidong Zhu; Haitao Li; Timothy Schlub; Wijeyanthy Wijeyakumar; Andrew Alexander Chang

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):3937. doi:

ARVO Annual Meeting Abstract April 2014

Self-Controlled Comparison of the Anatomical and Visual Response to Intravitreal Ranibizumab and Aflibercept in Treatment-Resistant Age-Related Macular Degeneration

Andrew Alexander Chang; Thomas Hong; Geoffrey Broadhead; Nichole Diane Lucy Joachim; Adil Syed; Timothy Schlub; Wijeyanthy Wijeyakumar; Meidong Zhu

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):3939. doi:

ARVO Annual Meeting Abstract April 2014

Changes in Quality of Life Among Patients Treated with Aflibercept for neovascular Age-related Macular Degeneration (nAMD)

Wijeyanthy Wijeyakumar; Thomas Hong; Geoffrey Broadhead; Haitao Li; Meidong Zhu; Andrew Alexander Chang; Sydney Institute of Vision Science

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):3945. doi:

ARVO Annual Meeting Abstract April 2014

CORRELATING CHANGES IN MACULAR FUNCTION WITH ANTOMICAL PATHOLOGY IN TRACTIONAL EPIRETINAL MEMBRANE

Adil Syed; Thomas Hong; Geoffrey Broadhead; Meidong Zhu; Andrew Alexander Chang

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):5946. doi:

ARVO Annual Meeting Abstract April 2014

EVALUATION OF A DIRECT APPROACH TO EYE DONATION IN A POPULATION WITH RETINAL DISEASES

Meidong Zhu; Adil Syed; Nichole Diane Lucy Joachim; Kehui Luo; Con Petsoglou; Andrew Alexander Chang

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):681. doi:

Advertisement